Annovis Bio Inc.

1.61
0.12 (8.05%)
At close: Apr 02, 2025, 3:59 PM
1.52
-5.59%
After-hours: Apr 02, 2025, 07:56 PM EDT

Annovis Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Revenue n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income n/a -45.04M -25.51M -14.54M -6.64M -1.61M -713.94K -682.43K
Interest Income 331.85M 667.9M 182.71K 13.34K 47.23K n/a n/a n/a
Pretax Income -24.59B -56.2M -25.33M -14.49M -5.46M -990.98K -713.87K -682.35K
Net Income -24.59B -56.2M -25.15M -14.44M -4.26M -296.84K -713.87K -682.35K
Selling & General & Admin 6.7B 6.24M 9M 6.06M 3.59M 829.37K 602.33K 409.06K
Research & Development 20B 38.79M 16.52M 8.48M 3.05M 776.26K 111.61K 273.37K
Other Expenses n/a n/a n/a -36.75K -1.16M -735.08K n/a n/a
Operating Expenses 26.69B 45.04M 25.51M 14.5M 5.48M 870.55K 713.94K 682.43K
Interest Expense n/a n/a n/a n/a 47.23M n/a 66.00 84.00
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses n/a 45.04M 25.51M 14.5M 5.48M 870.55K 713.94K 682.43K
Income Tax n/a n/a -182.71K -50.09K -1.2M -694.14K -132 -682.43K
Shares Outstanding (Basic) 12.18M 9.02M 8.16M 7.63M 6.31M 4.5M 4.4M 4.39M
Shares Outstanding (Diluted) 12.24M 9.02M 8.16M 7.63M 6.31M 4.5M 4.4M 4.39M
EPS (Basic) -2.02K -6.23 -3.08 -1.89 -0.67 -0.07 -0.16 -0.16
EPS (Diluted) -2.01K -6.23 -3.08 -1.89 -0.67 -0.07 -0.16 -0.16
EBITDA n/a -45.04M n/a n/a n/a n/a 66.00 84.00
EBIT n/a -45.04M -25.33M -14.49M -5.46M -1.61M -713.87K -682.35K
Depreciation & Amortization n/a 1.00 25.51M 14.54M 6.64M 1.61M 713.94K 682.43K